International MOU inked between chemistry and biomedical talents from Hong Kong, Singapore and Europe for late-stage cancer research enhancement. 27 7 月, 2022 Read More »
Xylonix and Invitrocue form strategic clinical alliance to validate new method for combating IL-6 pathologies 28 4 月, 2026 Read More >>
Invitrocue and Angsana partner with Averywell to advance early lung cancer detection across Asia 15 4 月, 2026 Read More >>
